Association between NR5A2 and the risk of pancreatic cancer, especially among Caucasians: a meta-analysis of case–control studies

References

• DucreuxMCuhnaASCaramellaCESMO Guidelines CommitteeCancer of the pancreas: ESMO clinical practice guidelines for diagnosis, treatment and follow-upAnn Oncol201526Suppl 5v56v6826314780
   PubMed Web of Science ®Google Scholar
• VincentAHermanJSchulickRHrubanRHGogginsMPancreatic cancerLancet2011378979160762021620466
   PubMed Web of Science ®Google Scholar
• SiegelRLMillerKDJemalACancer statistics, 2016CA Cancer J Clin201666173026742998
   PubMed Web of Science ®Google Scholar
• ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
   PubMed Web of Science ®Google Scholar
• LiaoXHuangKHuangRGenome-scale analysis to identify prognostic markers in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomyOnco Targets Ther2017104493450628979141
   PubMed Web of Science ®Google Scholar
• GroverSSyngalSHereditary pancreatic cancerGastroenterology201013941076108020727885
   PubMed Web of Science ®Google Scholar
• AnsariDRosendahlAElebroJAnderssonRSystematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancerBr J Surg20119881041105521644238
   PubMed Web of Science ®Google Scholar
• LazarusKAWijayakumaraDChandALSimpsonERClyneCDTherapeutic potential of liver receptor homolog-1 modulatorsJ Steroid Biochem Mol Biol20121303–513814622266285
   PubMed Web of Science ®Google Scholar
• LeeYKMooreDDLiver receptor homolog-1, an emerging metabolic modulatorFront Biosci2008135950595818508634
   PubMed Web of Science ®Google Scholar
• GuidoVFJohnPMChristopherWMatthiasHNr5a2 maintains acinar cell differentiation and constrains oncogenic Kras-mediated pancreatic neoplastic initiationGut201463465666423645620
   PubMed Web of Science ®Google Scholar
• MurtaughLCPutting GWAS to the functional test: NR5A2 and pancreatic cancer riskGut201463453553623759730
   PubMed Web of Science ®Google Scholar
• PetersenGMAmundadottirLFuchsCSA genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33Nat Genet201042322422820101243
   PubMed Web of Science ®Google Scholar
• ZhangXGuDDuMAssociations of NR5A2 gene polymorphisms with the clinicopathological characteristics and survival of gastric cancerInt J Mol Sci20141512229022291725514243
   PubMed Web of Science ®Google Scholar
• HandollHHSystematic reviews on rehabilitation interventionsArch Phys Med Rehabil20068787516731227
   PubMed Web of Science ®Google Scholar
• HigginsJPThompsonSGDeeksJJAltmanDGMeasuring inconsistency in meta-analysesBMJ2003327741455756012958120
   PubMed Web of Science ®Google Scholar
• DerSimonianRLairdNMeta-analysis in clinical trialsControl Clin Trials1986731771883802833
   PubMedGoogle Scholar
• MantelNHaenszelWStatistical aspects of the analysis of data from retrospective studies of diseaseJ Natl Cancer Inst195922471974813655060
   PubMed Web of Science ®Google Scholar
• MakotoUShinichiOManabuMGenome-wide association study-identified SNPs (rs3790844, rs3790843) in the NR5A2 gene and risk of pancreatic cancer in JapaneseSci Rep201551701826592175
   PubMed Web of Science ®Google Scholar
• HongweiTXiaoqunDManalHBody mass index and obesity-and diabetes-associated genotypes and risk for pancreatic cancerCancer Epidemiol Biomarkers Prev201120577979221357378
   PubMed Web of Science ®Google Scholar
• CosmeriRDanieleCNathaliaGPancreatic cancer susceptibility loci and their role in survivalPLoS One2011611e2792122125638
   PubMed Web of Science ®Google Scholar
• AlisonPKSaraLJulieBMAn absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general populationPLoS One201389e7231124058443
   PubMed Web of Science ®Google Scholar
• YaoYA Case Control Study of Pancreatic Cancer with Environmental, Diease, Psychological, Behavioral Factors and the Preliminary Study of Genetic Predisposition in Pancreatic Cancer.caj [D]PekingPeking Union Medical College2013
   Google Scholar
• SiegelRMaJZouZJemalACancer statistics, 2014CA Cancer J Clin201464192924399786
   PubMed Web of Science ®Google Scholar
• SteeleCWKarimSALeachJDGCXCR2 inhibition profoundly suppresses metastases and augments immunotherapy in pancreatic ductal adenocarcinomaCancer Cell201629683284527265504
   PubMed Web of Science ®Google Scholar
• FerroneCRPieretti-VanmarckeRBloomJPPancreatic ductal adenocarcinoma: long-term survival does not equal cureSurgery20121523 Suppl 1S43S4922763261
   PubMed Web of Science ®Google Scholar
• SiegelRLMillerKDJemalACancer statistics, 2015CA Cancer J Clin201565152925559415
   PubMed Web of Science ®Google Scholar
• Von HoffDDErvinTArenaFPIncreased survival in pancreatic cancer with nab-paclitaxel plus gemcitabineN Engl J Med2013369181691170324131140
   PubMed Web of Science ®Google Scholar
• HidalgoMPancreatic cancerN Engl J Med2010362171605161720427809
   PubMed Web of Science ®Google Scholar
• ShinEJCantoMIPancreatic cancer screeningGastroenterol Clin North Am201241114315722341255
   PubMed Web of Science ®Google Scholar
• KamisawaTWoodLDItoiTTakaoriKPancreatic cancerLancet201638810039738526830752
   PubMed Web of Science ®Google Scholar
• BaileyPChangDKNonesKGenomic analyses identify molecular subtypes of pancreatic cancerNature20165317592475226909576
   PubMed Web of Science ®Google Scholar
• FlandezMCendrowskiJCanameroMNr5a2 heterozygosity sensitises to, and cooperates with, in ammation in KRasG12V-driven pancreatic tumourigenesisGut201463464765523598351
   PubMed Web of Science ®Google Scholar
• HolmstromSRDeeringTSwiftGHLRH-1 and PTF1-L coregu-late an exocrine pancreas-specific transcriptional network for digestive functionGenes Dev201125161674167921852532
   PubMed Web of Science ®Google Scholar
• CarriereCYoungALGunnJRLongneckerDSKorcMAcute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic KrasBiochem Biophys Res Commun2009382356156519292977
   PubMed Web of Science ®Google Scholar
• BenodCVinogradovaMVJouravelNKimGEFletterickRJSablinEPNuclear receptor liver receptor homologue 1 (LRH-1) regulates pancreatic cancer cell growth and proliferationProc Natl Acad Sci U S A201110841169271693121949357
   PubMed Web of Science ®Google Scholar
• DuboisMJBergeronSKimHJThe SHP-1 protein tyrosine phosphatase negatively modulates glucose homeostasisNat Med200612554955616617349
   PubMed Web of Science ®Google Scholar
• IwakiMMatsudaMMaedaNInduction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptorsDiabetes20035271655166312829629
   PubMed Web of Science ®Google Scholar
• XuPOosterveerMHSteinSLRH-1-dependent programming of mitochondrial glutamine processing drives liver cancerGenes Dev201630111255126027298334
   PubMed Web of Science ®Google Scholar
• ZhuJZouZNiePDownregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1 expressionCell Death Dis2016711e245427809310
   PubMed Web of Science ®Google Scholar
• AnnicotteJSChaveyCServantNThe nuclear receptor liver receptor homolog-1 is an estrogen receptor target geneOncogene200524558167817516091743
   PubMed Web of Science ®Google Scholar
• YuanQCaoGLiJZhangYYangWMicroRNA-136 inhibits colon cancer cell proliferation and invasion through targeting liver receptor homolog-1/Wnt signalingGene2017628485528710032
   PubMed Web of Science ®Google Scholar
• LiZWuSLvSWangHWangYGuoQSuppression of liver receptor homolog-1 by microRNA-451 represses the proliferation of osteosarcoma cellsBiochem Biophys Res Commun2015461345045525869073
   PubMed Web of Science ®Google Scholar
• ZimmerVMihalacheFHöblingerAThe frequent NR5A2 gene variant rs3790844 mediates an increased risk of cholangiocarcinoma in a large European cohortZ Gastroenterol201149429
   Google Scholar